Page 4 - Dolma Bagi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dolma bagi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dolma Bagi Today - Breaking & Trending Today

Olema Pharmaceuticals (NASDAQ:OLMA) Trading 8.3% Higher

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) traded up 8.3% during trading on Wednesday . The company traded as high as $17.20 and last traded at $17.20. 34,407 shares changed hands during trading, a decline of 88% from the average session volume of 288,567 shares. The stock had previously closed at $15.88. […] ....

Cyrus Harmon , Davidc Myles , Credit Suisse Group , Ameriprise Financial Inc , Olema Pharmaceuticals Inc , Olema Pharmaceuticals Price Performance , Olema Pharmaceuticals , Acuta Capital Partners , Securities Exchange Commission , Jpmorgan Chase Co , News Ratings For Olema Pharmaceuticals Daily , Capital Management , Institutional Investors Weigh In On Olema Pharmaceuticals , Get Free Report , Suisse Group , Director Cyrus Harmon , Exchange Commission , Capital Partners , Olema Pharmaceuticals Daily , Nasdaq Olma ,

Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 4.9%

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) fell 4.9% during trading on Monday . The company traded as low as $15.01 and last traded at $15.06. 209,613 shares were traded during trading, a decline of 27% from the average session volume of 285,469 shares. The stock had previously closed at $15.83. Analyst Ratings Changes […] ....

Cyrus Harmon , News Ratings For Olema Pharmaceuticals Daily , Jpmorgan Chase Co , Olema Pharmaceuticals Company Profile , Olema Pharmaceuticals Inc , Acadian Asset Management , Olema Pharmaceuticals , Hedge Funds Weigh In On Olema Pharmaceuticals , Credit Suisse Group , Ep Wealth Advisors , Royal Bank , Olema Pharmaceuticals Stock Performance , Get Free Report , Suisse Group , Director Cyrus Harmon , Director Bvf Partners , Asset Management , Olema Pharmaceuticals Daily , Nasdaq Olma ,

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Director Sells $78,200.00 in Stock

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of Olema Pharmaceuticals stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $15.64, for a total transaction of $78,200.00. Following the transaction, the director now directly owns 943,714 shares of the […] ....

United States , Cyrus Harmon , Quarter For Olema Pharmaceuticals , Credit Suisse Group , Olema Pharmaceuticals Inc , Ep Wealth Advisors , Wells Fargo Company , Olema Pharmaceuticals Stock Performance , News Ratings For Olema Pharmaceuticals Daily , Olema Pharmaceuticals , Jpmorgan Chase Co , Citigroup Inc , Royal Bank , Get Free Report , Director Cyrus Harmon , State Teachers Retirement System , Wells Fargo , Suisse Group , Olema Pharmaceuticals Daily , Nasdaq Olma , Insider Trading , Nsider Trades ,